Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
The Laryngoscope
|
July 14, 2019
Pattern and severity of transverse sinus stenosis in patients with pulsatile tinnitus associated with sigmoid sinus wall anomalies
Daniel Hewes, Robert Morales, Prashant Raghavan, et al.
American Journal of Otolaryngology
|
December 26, 2023
Longitudinal outcomes with intracapsular tonsillectomy, a single surgeon's experience
Malek H Bouzaher, Daniel Hewes, Mario Belfiglio, et al.
Experimental and Molecular Pathology
|
July 21, 2018
Phosphorylated SIRT1 as a biomarker of relapse and response to treatment with glatiramer acetate in multiple sclerosis
Jonathan Ciriello, Alexandru Tatomir, Daniel Hewes, et al.
ACS Catalysis
|
April 25, 2022
Impact of the Experimental Parameters on Catalytic Activity When Preparing Polymer Protected Bimetallic Nanoparticle Catalysts on Activated Carbon
Charlie B Paris, Alexander G Howe, Richard James Lewis, et al.
Experimental and Molecular Pathology
|
January 23, 2017
SIRT1 as a potential biomarker of response to treatment with glatiramer acetate in multiple sclerosis
Daniel Hewes, Alexandru Tatomir, Adam M Kruszewski, et al.
Experimental and Molecular Pathology
|
September 27, 2015
RGC-32 as a potential biomarker of relapse and response to treatment with glatiramer acetate in multiple sclerosis
Adam M Kruszewski, Gautam Rao, Alexandru Tatomir, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
The Laryngoscope
|
July 14, 2019
Pattern and severity of transverse sinus stenosis in patients with pulsatile tinnitus associated with sigmoid sinus wall anomalies
Daniel Hewes, Robert Morales, Prashant Raghavan, et al.
American Journal of Otolaryngology
|
December 26, 2023
Longitudinal outcomes with intracapsular tonsillectomy, a single surgeon's experience
Malek H Bouzaher, Daniel Hewes, Mario Belfiglio, et al.
Experimental and Molecular Pathology
|
July 21, 2018
Phosphorylated SIRT1 as a biomarker of relapse and response to treatment with glatiramer acetate in multiple sclerosis
Jonathan Ciriello, Alexandru Tatomir, Daniel Hewes, et al.
ACS Catalysis
|
April 25, 2022
Impact of the Experimental Parameters on Catalytic Activity When Preparing Polymer Protected Bimetallic Nanoparticle Catalysts on Activated Carbon
Charlie B Paris, Alexander G Howe, Richard James Lewis, et al.
Experimental and Molecular Pathology
|
January 23, 2017
SIRT1 as a potential biomarker of response to treatment with glatiramer acetate in multiple sclerosis
Daniel Hewes, Alexandru Tatomir, Adam M Kruszewski, et al.
Experimental and Molecular Pathology
|
September 27, 2015
RGC-32 as a potential biomarker of relapse and response to treatment with glatiramer acetate in multiple sclerosis
Adam M Kruszewski, Gautam Rao, Alexandru Tatomir, et al.
Page
of 1